-
Li Li meets with secretary for social affairs and culture of Macao SAR
2025-08-06
Li Li, commissioner of the National Medical Products Administration (NMPA), met with a delegation led by O Lam, secretary for social affairs and culture of the Macao Special Administrative Region (SAR), in Beijing on July 24.
-
China-EU exchange on cosmetics regulatory system held in Beijing
2025-07-25
An exchange event on cosmetics regulatory system between China and the European Union (EU) was held in Beijing on July 16. Xu Jinghe, deputy commissioner of China's National Medical Products Administration (NMPA), attended the meeting.
-
Policy Interpretation of the Quality Management Specifications for Online Sales of Medical Devices
2025-07-21
With the rapid development of e-commerce, the online medical device sales market in China has experienced explosive growth in recent years. According to statistics, from 2018 to the present, the number of medical device distributors engaged in online sales has increased from 8,717 to over 360,000, while the number of third-party platform enterprises has grown from 77 to 851.
-
Policy Interpretation of Provisions on the Experimental Research of Narcotic Drugs and Psychotropic Substances
2025-07-21
To strengthen the safety management of experimental research involving narcotic and psychotropic drugs, the Provisions propose requirements from multiple aspects, including safety management systems and facilities and equipment, entrusted research management, management of experimental researchers, and management of narcotic and psychotropic drugs and active substances.
-
Announcement of the National Medical Products Administration (NMPA) on Matters Related to the Administration of the Inventory of Existing Cosmetic Ingredients (IECIC) (No. 61 of 2025)
2025-07-21
To implement the Regulations on Supervision and Administration of Cosmetics, further regulate the administration of cosmetic ingredients, and encourage innovation in raw materials, the following matters concerning the Inventory of Existing Cosmetic Ingredients (hereinafter referred to as the Inventory) are hereby announced.
-
Chinese vice-premier calls for boosting basic pharmaceutical research, sci-tech innovation
2025-07-11
Liu, also a member of the Political Bureau of the Communist Party of China Central Committee, visited Peking University's School of Pharmaceutical Sciences to learn about medical research and development, as well as the construction and operations of key laboratories, and listened to opinions from various relevant parties at a symposium.
